The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Perioperative chemotherapy using FOLFOX with panitumumab for locally advanced rectal cancer: Phase II trial.
 
Mitsuyoshi Ota
Speakers' Bureau - Chugai Pharma; Covidien; Ethicon; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Research Funding - Sysmex; TOTO; Yakult Pharmaceutical
 
Jun Watanabe
No Relationships to Disclose
 
Atsushi Ishibe
No Relationships to Disclose
 
Hirokazu Suwa
No Relationships to Disclose
 
Masashi Momiyama
No Relationships to Disclose
 
Yasushi Ichikawa
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Chugai Pharma; Merck Serono; Mochida Pharmaceutical Co. Ltd.; Ono Pharmaceutical; Sanofi; Shionogi; Taiho Pharmaceutical; Takeda; Takeda; Takeda; Takeda; TERUMO; TERUMO; Yakult Honsha
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Eisai (Inst); Merck Serono (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)
 
Chikara Kunisaki
No Relationships to Disclose
 
Itaru Endo
No Relationships to Disclose